CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
Summary
Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United States
Description
Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United States
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source